SRPT Rallies on FDA Green Light: A New Bottom for the Stock? скачать в хорошем качестве

SRPT Rallies on FDA Green Light: A New Bottom for the Stock?

Sarepta Therapeutics (SRPT) jumped on Tuesday's session after the FDA lifted a voluntary pause on the company's gene therapy treatment for patients with Duchenne muscular dystrophy. The drug was pulled earlier this year to determine if it was tied to a patient's death. George Tsilis talks about the possibility of this being an "inflection bottom" for the stock, though analysts remain divided on whether that's actually the case. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-... Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-... Watch on Sling - https://watch.sling.com/1/asset/19192... Watch on Vizio - https://www.vizio.com/en/watchfreeplu... Watch on DistroTV - https://www.distro.tv/live/schwab-net... Follow us on X –   / schwabnetwork   Follow us on Facebook –   / schwabnetwork   Follow us on LinkedIn -   / schwab-network   About Schwab Network - https://schwabnetwork.com/about #srpt #biotech #smallcapstocks #economy #finance #investing #marketnews #stock #stockmarket #trading #live #schwabnetwork #sarepta #theraputic #biomedical #fda